Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
Ticagelor is a drug that prevents platelets from clumping together. It is used to prevent strokes, heart attacks, and other occurrences in persons who have acute coronary syndrome, which is a condition in which blood supply to the heart is disrupted. coronary arteries are the blood vessels in the heart. It works as a platelet aggregation inhibitor by inhibiting blood clotting. Blocking the P2Y 12 receptor It has a half-life of up to 12 hours. Hepatic metabolism and biliary excretion are two types of metabolism. review gives the information about different method of estimation of Ticagelor. That includes the review on pharmaceutical analytical techniques like High-performance liquid chromatography, Reverse phase - High-performance liquid chromatography, Bio-analytical techniques, Spectrometry with the impurities, pharmaceutical dosage forms, bulk, and its formulations used for determination and validation. This review helps us to get updated information on validation of drug-Ticagelor till current date.
Keywords:
Ticagelor, HPLC, U. V, validate, impurities
Cite Article:
"Different estimation method of Ticagrelor", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.7, Issue 5, page no.812 - 818, May-2022, Available :http://www.ijrti.org/papers/IJRTI2205134.pdf
Downloads:
000205264
ISSN:
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator